Advertisement
Joining Mr. Senshan Yang, Chairman and Chief Executive Officer of ChinaMedicine Corporation, will be Ms. Huizhen Yu, Chief Financial Officer. TheCompany plans to make an earnings announcement prior to the call.
Advertisement
To participate in the live conference call, please dial the followingnumber five to ten minutes prior to the scheduled conference call time:866.800.8648. International callers should dial 617.614.2702, conferencepasscode: 175 848 10.
If you are unable to participate in the call at this time, a replay willbe available for 14 days starting on Thursday, August 13, at 12:00 p.m.Eastern Time. To access the replay, dial 888.286.8010, international callersdial 617.801.6888, and enter the passcode 442 846 06.
About China Medicine Corporation
China Medicine Corporation is a leading pharmaceutical company thatdiscovers and develops medical formulations and distributes over 2,400pharmaceutical products in China including prescription and over the counter("OTC") drugs, traditional Chinese medicine products, herbs and dietary-supplements. The Company distributes its products to wholesale distributors in28 provinces, more than 300 hospitals, 500 medicine companies, and 1,788 drugstores throughout China. The Company actively develops a number of proprietaryproducts for a variety of uses, including oncology, high blood pressure andthe removal of toxins from food and animal feeds. For more information visitthe Company's website at http://www.chinamedicinecorp.com .For more information, please contact: Company Contact: Ms. Huizhen Yu Chief Financial Officer China Medicine Corporation Tel: +86-20-8739-1718 Email: [email protected] Investor Relations Contact: Mr. Crocker Coulson President CCG Investor Relations Tel: +1-646-213-1915 (NY Office) Email: [email protected] Web: http://www.ccgirasia.com
SOURCE China Medicine Corporation
